## Review

### Scores

| Criterion | Score (0–100) | Assessment |
|---|---:|---|
| **Soundness** | **45** | The experimental results are plausible and the proposed architecture is technically coherent, but important methodological details are missing. The paper does not adequately specify sepsis-onset labeling, censoring, handling of multiple ICU stays, preprocessing/imputation, hourly window construction, or prevention of label leakage. Baseline tuning also appears potentially unfair: TimeWarn is tuned over 72 configurations, whereas baselines use hyperparameters from their original papers. No confidence intervals or statistical significance tests are reported. |
| **Novelty** | **40** | The central idea—using learned time decay to modulate RETAIN-style visit- and variable-level attention—is a reasonable combination of existing ideas, but it appears incremental. It overlaps substantially with GRU-D-style temporal decay and established interpretable attention mechanisms. The paper does not clearly distinguish TimeWarn from prior time-aware attention, decay-based attention, or irregular-time EHR models. |
| **Significance** | **55** | Early sepsis prediction is clinically important, and evaluation on both MIMIC-IV and eICU is potentially valuable. The reported improvements over GRU-D are modest but potentially meaningful. However, the retrospective ICU-only evaluation, absence of prospective or workflow evaluation, and limited analysis of calibration, false-alert burden, subgroup performance, and clinical utility substantially limit the practical significance. |
| **Clarity** | **70** | The manuscript is well organized and generally easy to follow. The motivation, architecture, and headline results are presented clearly. However, the method and experimental protocol lack enough detail for reproduction, and some claims are overstated. In particular, attention weights should not be presented as definitive explanations without validation, and lactate is not itself a direct Sepsis-3 diagnostic criterion. |

### Final average

\[
\frac{45 + 40 + 55 + 70}{4} = \mathbf{52.5}
\]

### Recommendation: **Reject**

The paper addresses an important problem and reports promising results, but the current version does not establish sufficient methodological rigor or novelty for acceptance. The most important issues are incomplete specification of the cohort and labeling protocol, unclear handling of irregular measurements and missingness, potentially inconsistent baseline tuning, lack of statistical comparisons, and limited differentiation from existing time-aware models such as GRU-D. A substantially revised version with a stronger experimental protocol, fair baseline optimization, leakage and label-timing analyses, calibration and clinical-utility results, and a more comprehensive novelty comparison could become competitive.